scholarly article | Q13442814 |
P50 | author | Hyo-Jick Choi | Q57037509 |
Ilaria Rubino | Q59680725 | ||
P2093 | author name string | Fu-Shi Quan | |
Bongyoung Yoo | |||
Brendan Koch | |||
P2860 | cites work | Concentrated insulins: the new basal insulins | Q26750438 |
MEMS-enabled implantable drug infusion pumps for laboratory animal research, preclinical, and clinical applications | Q27022363 | ||
Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin. | Q45990071 | ||
Development of a codrug approach for sustained drug delivery across microneedle-treated skin. | Q46026982 | ||
Skin penetration enhancement by a microneedle device (Dermaroller) in vitro: dependency on needle size and applied formulation | Q46161199 | ||
Characterization of surface-modified nanoparticles for in vivo biointeraction. A sedimentation field flow fractionation study | Q46677027 | ||
Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy | Q46788910 | ||
Evaluation of self-dissolving needles containing low molecular weight heparin (LMWH) in rats | Q47271319 | ||
Microneedle integrated transdermal patch for fast onset and sustained delivery of lidocaine. | Q47970244 | ||
Microstamp patterns of biomolecules for high-resolution neuronal networks | Q48007909 | ||
Adjuvants to prolong the local anesthetic effects of coated microneedle products | Q48127170 | ||
Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action | Q48249216 | ||
Novel microneedle patches for active insulin delivery are efficient in maintaining glycaemic control: an initial comparison with subcutaneous administration | Q48611030 | ||
Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. | Q50453540 | ||
Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant. | Q50895576 | ||
Fear of injections in young adults: prevalence and associations. | Q51027319 | ||
Insulin loaded eudragit L100 microspheres for oral delivery: preliminary in vitro studies. | Q51280152 | ||
Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. | Q51658246 | ||
Inkjet printing of transdermal microneedles for the delivery of anticancer agents. | Q53330393 | ||
Structural characterisation and transdermal delivery studies on sugar microneedles: experimental and finite element modelling analyses. | Q53367599 | ||
Cancer cell resistance to aurora kinase inhibitors: identification of novel targets for cancer therapy. | Q54471825 | ||
A BioMEMS Review: MEMS Technology for Physiologically Integrated Devices | Q56405824 | ||
Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose | Q57152681 | ||
Drawing lithography: three-dimensional fabrication of an ultrahigh-aspect-ratio microneedle | Q57154601 | ||
Responsive hydrogels – structurally and dimensionally optimized smart frameworks for applications in catalysis, micro-system technology and material science | Q57364677 | ||
A prospective trial comparing small bowel radiographs and video capsule endoscopy for suspected small bowel disease | Q57941950 | ||
A controlled-release microchip | Q59058736 | ||
Wireless capsule endoscopy | Q59062863 | ||
Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery | Q59885457 | ||
Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses | Q64445619 | ||
Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin | Q64445621 | ||
Bioadhesion by means of specific binding of tomato lectin | Q68006461 | ||
Controlled trial of transdermal nicotine patch in tobacco withdrawal | Q69366999 | ||
A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators | Q71980414 | ||
Biocompatibility and biofouling of MEMS drug delivery devices | Q73075117 | ||
Lack of pain associated with microfabricated microneedles | Q73399627 | ||
Multimechanism oral dosage forms fabricated by three dimensional printing | Q73526416 | ||
Microchips as Controlled Drug-Delivery Devices | Q74166130 | ||
What are narrow therapeutic index drugs? | Q74662788 | ||
Drug-eluting stents | Q75343529 | ||
Nanostructure-mediated drug delivery | Q79755442 | ||
Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques | Q80204825 | ||
Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery | Q82770641 | ||
An implantable MEMS drug delivery device for rapid delivery in ambulatory emergency care | Q83239710 | ||
A bottom-up approach to fabricate patterned surfaces with asymmetrical TiO2 microparticles trapped in the holes of honeycomblike polymer film | Q83470320 | ||
The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin | Q84224929 | ||
Vaccine discovery and translation of new vaccine technology | Q84336201 | ||
Simultaneous basal-bolus delivery of fast-acting insulin and its significance in diabetes management | Q84443425 | ||
Investigation on fabrication process of dissolving microneedle arrays to improve effective needle drug distribution | Q86103667 | ||
Biocompatibility of common polyimides with human endothelial cells for a cardiovascular microsensor | Q86314828 | ||
Aluminum compounds as vaccine adjuvants | Q95787646 | ||
Micro- and nano-fabricated implantable drug-delivery systems | Q38074444 | ||
Potential of biodegradable microneedles as a transdermal delivery vehicle for lidocaine | Q38108243 | ||
A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules | Q38237549 | ||
Delivery strategies to enhance oral vaccination against enteric infections. | Q38393940 | ||
Two-photon polymerization microfabrication of hydrogels: an advanced 3D printing technology for tissue engineering and drug delivery | Q38493600 | ||
Strategic role of selected noble metal nanoparticles in medicine. | Q38531727 | ||
Targeting to intestinal M cells | Q38559959 | ||
Impedance characterization, degradation, and in vitro biocompatibility for platinum electrodes on BioMEMS | Q38911630 | ||
Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy | Q39559865 | ||
Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia | Q39577142 | ||
Surface modification of silicon and gold-patterned silicon surfaces for improved biocompatibility and cell patterning selectivity. | Q40463849 | ||
Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque. | Q42156511 | ||
A Novel Device for Islet Transplantation Providing Immune Protection and Oxygen Supply | Q42843950 | ||
A microneedle roller for transdermal drug delivery | Q42972564 | ||
Pharmacokinetic and pharmacodynamic evaluation of insulin dissolving microneedles in dogs | Q43063263 | ||
Transdermal delivery of insulin using microneedle rollers in vivo | Q43116870 | ||
Microneedle pretreatment improves efficacy of cutaneous topical anesthesia | Q43160498 | ||
Super-short solid silicon microneedles for transdermal drug delivery applications | Q43185564 | ||
Nicotine patch use in the general population: results from the 1993 California Tobacco Survey | Q43547803 | ||
Tapered conical polymer microneedles fabricated using an integrated lens technique for transdermal drug delivery | Q43548910 | ||
An in vivo/in vitro comparison with a leuprolide osmotic implant for the treatment of prostate cancer | Q43672627 | ||
Nanoporous biocapsules for the encapsulation of insulinoma cells: biotransport and biocompatibility considerations | Q43784669 | ||
Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs | Q45760750 | ||
Human immune responses to influenza virus vaccines administered by systemic or mucosal routes | Q45772716 | ||
Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery. | Q45985486 | ||
Small-scale systems for in vivo drug delivery | Q28206028 | ||
Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts | Q28387541 | ||
RGD and other recognition sequences for integrins | Q29616331 | ||
Development of phosphorylated glucomannan-coated chitosan nanoparticles as nanocarriers for protein delivery. | Q30357505 | ||
Challenges and opportunities in dermal/transdermal delivery | Q30432573 | ||
Micromechanical devices for intravascular drug delivery | Q30472814 | ||
Microneedle patches: usability and acceptability for self-vaccination against influenza | Q30575700 | ||
Nanoparticles of biodegradable polymers for clinical administration of paclitaxel | Q31047920 | ||
Evaluation of MEMS materials of construction for implantable medical devices. | Q31075038 | ||
Application of micro- and nano-electromechanical devices to drug delivery | Q33244216 | ||
Industrial applications of laser micromachining | Q33436689 | ||
Development and characterization of polymeric microspheres for controlled release protein loaded drug delivery system | Q33521681 | ||
Two-photon polymerization of microneedles for transdermal drug delivery | Q33537346 | ||
Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique | Q33583706 | ||
Metal microneedle fabrication using twisted light with spin. | Q33664509 | ||
Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies | Q33712814 | ||
Local transdermal delivery of phenylephrine to the anal sphincter muscle using microneedles. | Q33829439 | ||
Reform, regulation, and pharmaceuticals--the Kefauver-Harris Amendments at 50. | Q33913880 | ||
Biodegradable polymeric nanoparticles as drug delivery devices | Q33932406 | ||
Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines | Q33933255 | ||
Nano and microparticles as controlled drug delivery devices. | Q34037126 | ||
Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients | Q34074885 | ||
Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects | Q34167180 | ||
Survey of the prevalence of immunization non-compliance due to needle fears in children and adults | Q34278473 | ||
Exploiting M cells for drug and vaccine delivery | Q34328460 | ||
Novel mechanisms and devices to enable successful transdermal drug delivery | Q34334041 | ||
Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial | Q34336573 | ||
Hemocompatibility, biocompatibility, inflammatory and in vivo studies of primary reference materials low-density polyethylene and polydimethylsiloxane: a review | Q34337270 | ||
Microengineering of cellular interactions | Q34433138 | ||
Measurement of gastrointestinal pH profiles in normal ambulant human subjects | Q34530993 | ||
Hydrogels: from controlled release to pH-responsive drug delivery. | Q34669619 | ||
Rapidly-dissolvable microneedle patches via a highly scalable and reproducible soft lithography approach | Q34671534 | ||
Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery | Q34700358 | ||
Delivery technologies for human vaccines | Q34784860 | ||
A refillable microfabricated drug delivery device for treatment of ocular diseases | Q34789696 | ||
The efficacy of an immunoisolating membrane system for islet xenotransplantation in minipigs | Q34925101 | ||
Temperature- and pH-sensitive nanohydrogels of poly(N-Isopropylacrylamide) for food packaging applications: modelling the swelling-collapse behaviour | Q35092607 | ||
Kinetics of skin resealing after insertion of microneedles in human subjects | Q35187866 | ||
Delivery systems for intradermal vaccination | Q35214379 | ||
Rapid local anesthesia in humans using minimally invasive microneedles | Q35435168 | ||
Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes | Q35830197 | ||
Composite hydrogels of polyacrylamide and crosslinked pH-responsive micrometer-sized hollow particles | Q35853762 | ||
A microneedle patch containing measles vaccine is immunogenic in non-human primates | Q36011315 | ||
Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. | Q36020905 | ||
Evaluation of geometrical effects of microneedles on skin penetration by CT scan and finite element analysis | Q36066978 | ||
Microneedles for drug and vaccine delivery | Q36164749 | ||
Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch | Q36175711 | ||
An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine. | Q36215695 | ||
Pocketed microneedles for rapid delivery of a liquid-state botulinum toxin A formulation into human skin | Q36525754 | ||
Dissolving microneedles for transdermal drug delivery | Q36540738 | ||
Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles | Q36626140 | ||
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. | Q36627730 | ||
Thermo- and pH-responsive polymers in drug delivery | Q36663097 | ||
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). | Q36728740 | ||
Role of nanotechnology in targeted drug delivery and imaging: a concise review | Q36733049 | ||
Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice | Q36996938 | ||
Measles vaccination using a microneedle patch | Q36997297 | ||
The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience | Q37106340 | ||
Immune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB/c mice after microneedle array pretreatment | Q37209757 | ||
Transdermal drug delivery | Q37238479 | ||
Transplantation of human islets without immunosuppression | Q37340689 | ||
Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro | Q37375277 | ||
Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis | Q37511128 | ||
Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement | Q37836900 | ||
Advances in top-down and bottom-up surface nanofabrication: techniques, applications & future prospects | Q37966385 | ||
Lessons from innovation in drug-device combination products | Q37971445 | ||
Microneedle technologies for (trans)dermal drug and vaccine delivery | Q37985278 | ||
Medical device specificities: opportunities for a dedicated product development methodology. | Q38018978 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 8 | |
P921 | main subject | microfabrication | Q175538 |
drug delivery | Q1392806 | ||
P577 | publication date | 2016-08-01 | |
P1433 | published in | Materials | Q6786584 |
P1476 | title | Microfabrication for Drug Delivery | |
P478 | volume | 9 |
Q90026297 | Bottom-Up Fabrication of Multilayer Enteric Devices for the Oral Delivery of Peptides |
Q64077456 | Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals |
Q55399562 | Facile fabrication of microparticles with pH-responsive macropores for small intestine targeted drug formulation. |
Q30855198 | Smart Microparticles with a pH-responsive Macropore for Targeted Oral Drug Delivery |
Q42225402 | Synthesis and Drug Delivery Application of Thermo- and pH-Sensitive Hydrogels: Poly(β-CD-co-N-Isopropylacrylamide-co-IAM) |